Scientists at the Icahn School of Medicine at Mount Sinai have discovered a way ovarian cancer (OvCa) tumors can manipulate their environment to resist immunotherapy. The team’s research, involving ...

Investigators evaluated atezolizumab combined with bevacizumab and non–platinum-based chemotherapy for patients with recurrent ovarian cancer.

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 In the past decade, we have witnessed important gains in ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of ...

Gynecologic clear cell cancers are aggressive malignant neoplasms with low response rates to chemotherapy. Among patients with advanced clear cell ovarian and endometrial cancers who received ...

Perturb-map spatial genomics reveals the genes helping tumors grow and resist immunotherapy. The left image shows ovarian tumors in mice tissue, while the right image, enhanced by advanced technology, ...

Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab and pembrolizumab in ovarian cancer. Nicoletta Colombo, MD, PhD, associate ...

The Ovarcoming Cancer Conference brings together survivors, caregivers, and medical professionals to learn from world renowned experts on topics of greatest importance in the ovarian cancer landscape.

Event being held today at 8:00 a.m. ET in New York City features presentations from Ovarian Cancer Key Opinion Leaders, Clinicians, Statistical Experts, and IMUNON executives Investors, stakeholders, ...

She explained that although she had the affected organs removed, the cancer “came back a couple times in a lymph node” The international journalist underwent immunotherapy treatment CNN's Christiane ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Molecularly ...